Howell W M, Leung S T, Jones D B, Nakshabendi I, Hall M A, Lanchbury J S, Ciclitira P J, Wright D H
Molecular Immunology Group, Tenovus Laboratory, Southampton General Hospital, United Kingdom.
Hum Immunol. 1995 May;43(1):29-37. doi: 10.1016/0198-8859(94)00130-i.
CD is a gluten-sensitive enteropathy, strongly associated with expression of the DQA10501, DQB10201 genotype. CD patients have an increased risk of malignancy, particularly EATCL. However, it is controversial as to whether adults with EATCL represent a subgroup of patients with CD or should be regarded as a distinct entity. To investigate the genetic relationship between CD and EATCL, HLA class II DRB1, DQA1, and DQB1 typing of peripheral blood, frozen or paraffin-embedded biopsy tissue obtained from Caucasian patients with CD (n = 91) or EATCL (n = 47) was performed by PCR-SSOP typing. Genotype frequencies were compared with those observed in 151 unrelated control individuals. A total of 83 (91%) of 91 CD patients were of DQA10501, DQB10201 genotype (pc < 10(-6), RR = 522.2), compared with 40 (93%) of 43 EATCL patients (pc < 10(-6), RR = 44.2) with amplifiable DNA versus 35 (23%) of 151 controls. DRB103 frequencies were also elevated in both patient groups (79 of 91 in CD [87%; pc < 10(-6), RR = 24.5] and 38 of 40 in EATCL [95%; pc < 10(-6), RR = 70.7]) compared with controls (32 of 151, 21%). These results confirm previous studies of HLA associations in CD and also suggest that EATCL arises in individuals with the DQA10501, DQB10201 CD-predisposing genotype. However, the frequency of DRB103,04 heterozygotes was significantly increased in the EATCL group (16 of 40, 40%) compared with both control individuals (3 of 151, 2%; pc < 10(-6), RR = 32.9) and uncomplicated CD patients (6 of 91, 7%; pc = 0.04, RR = 9.4).(ABSTRACT TRUNCATED AT 250 WORDS)
乳糜泻是一种麸质敏感性肠病,与DQA10501、DQB10201基因型的表达密切相关。乳糜泻患者发生恶性肿瘤的风险增加,尤其是肠病相关T细胞淋巴瘤(EATCL)。然而,患有EATCL的成年人是乳糜泻患者的一个亚组还是应被视为一个独立的实体,这一点存在争议。为了研究乳糜泻和EATCL之间的遗传关系,对从患有乳糜泻(n = 91)或EATCL(n = 47)的白种人患者获取的外周血、冷冻或石蜡包埋活检组织进行了HLA II类DRB1、DQA1和DQB1基因分型,采用聚合酶链反应-序列特异性寡核苷酸探针(PCR-SSOP)分型法。将基因型频率与在151名无关对照个体中观察到的频率进行比较。91名乳糜泻患者中有83名(91%)为DQA10501、DQB10201基因型(pc < 10(-6),相对危险度RR = 522.2),相比之下,43名EATCL患者中有40名(93%)具有可扩增DNA(pc < 10(-6),RR = 44.2),而151名对照中有35名(23%)。两个患者组中DRB103频率也升高(乳糜泻组91名中有79名[87%;pc < 10(-6),RR = 24.5],EATCL组40名中有38名[95%;pc < 10(-6),RR = 70.7]),与对照组(151名中有32名,21%)相比。这些结果证实了先前关于乳糜泻中HLA关联的研究,也表明EATCL发生于具有DQA10501、DQB10201乳糜泻易感基因型的个体中。然而,与对照个体(151名中有3名,2%;pc < 10(-6),RR = 32.9)和无并发症的乳糜泻患者(91名中有6名,7%;pc = 0.04,RR = 9.4)相比,EATCL组中DRB103,04杂合子的频率显著增加(40名中有16名,40%)。(摘要截于250字)